OvaRex Phase III Trials Are Fully Enrolled
21st Jun 2006, 17:52 GMT
Ovarian Cancer Program Update
OvaRex Phase III Trials Are Fully Enrolled related news:
- OvaRex Phase III Trials Are Fully Enrolled — Medical News Today RSS/XML Feed
- Merck KGaA drops Parkinson's drug after clinical trials fail (AFP) — Yahoo! News: Health News
- ZymoGenetics completes enrollment in phase III trial — Pharmaceutical Business Review Latest News
- New Phase III Data Demonstrate That Abbott's HUMIRA(R) (Adalimumab) Sustained Reduction in Signs and Symptoms Through One Year in Patients With Ankylosing Spondylitis — PR Newswire: All Releases
- ViRexx Medical Corp.: ViRexx Announces Completion of Enrollment for Phase III OvaRex'R' MAb Trials — Market Wire - Pharmaceuticals and Biotech
- Merck stops work on Parkison's compound (AP) — Yahoo! News: Health News
- Merck Stops Work on Parkison's Compound — AP Top Health News At 4:24 a.m. EDT
- Merck stops work on Parkison's compound (Associated Press) — Yahoo! Health: Health News
- Merck Drops New Parkison's Disease Drug — StratWire - Business of Healthcare NewsFeed
- New HDTV trials set to start here — Business Times Online - All The Headlines
Latest news from Obstetrics/ Gynecology News from StratCenter.com:
- Acusphere Reports Q3 2006 Financial Results and Accomplishments
- CuraGen and TopoTarget Announce Initiation of NCI-Sponsored Phase II Trial of PXD101 for Ovarian Cancer
- Twin Cities Takes Action to Save Babies
- Substantial Regression of Atherosclerosis May Help Improve Diseased Arteries
- EDAP TMS SA to Participate in Int'l Urology Conferences
- Misonix Showcases SonicOne Ultrasonic Wound Debrider with Medline at MEDICA 2006 in Germany
- 8 Studies Evaluating Cytyc's Novasure System Presented at AAGL Meeting